Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.

Skip to main content

Table 3 The unit cost associated with TAVI and SAVR in current Iran’s clinical pathway for AS treatment

From: Transcatheter aortic valve implantation against conventional aortic valve replacement surgery in high-risk patients with aortic stenosis; a cost-effectiveness analysis

cost Item*

Mean cost*

Standard Deviation

Distribution of Interest

Source

SAVR costs of the procedure

12,811,000 (51)

–-

 

[27]

TAVI costs of the procedure

20,052,000 (80)

–-

 

[27]

TAVI costs of hospitalization

43,200,000 (173)

4,032,654

Gamma

[28]

SAVR costs of hospitalization

75,750,000 (303)

4,326,731

Gamma

[28]

Stent costs TAVI

450,000,000 (1,800)

–-

 

[27]

Valve Costs

800,000,000 (3,200)

–-

 

[27]

Permanent Peace Maker Implantation Procedure or Implantable cardioverter defibrillators (ICDs)

Cost

9,183,500 (37)

–-

 

[27]

Cost of Angioplasty

7,398,300 (29)

–-

 

[27]

Reoperation TAVI

10,026,000 (40)

1,430,401

Gamma

[27]

Reoperation SAVR

6,405,500 (26)

2,720,528

Gamma

[27]

CABG

22,280,000 (89)

–-

 

[27]

  1. *All costs are Iranian Rial (US$ equivalent)